DCompany · Healthtech & Bio
Darwin Bioprospecting Excellence
Darwin Bioprospecting Excellence is a Valencia-based microbial biotechnology company that explores, discovers, and cultures novel microorganisms worldwide and turns them into industrial products, spanning Health & Nutrition (probiotics, functional foods, personalized nutrition) and Biosolutions (biogas, bioremediation, biocontrol, plastic-waste valorization). Founded in 2017 as a spin-off of the University of Valencia and CSIC, it holds a patent on a bacterium that acts as a magnet for microplastics and partnered with Repsol on polyolefin biodegradation technology.
Founded
2017
Founders
2
News
0
Rounds
1
Investors
5
SectorsBiotechnology, Microbial biotechnology, Probiotics & Functional Foods, Agricultural biologicals, Environmental biosolutions, Bioremediation
Start-up MapHealthtech & Bio › R&D tools & software for life sciences
Profile updated 31 Jul 2026
Founders
C
Cristina Vilanova
Chief Executive Officer & Co-founder
M
Manuel Porcar
Chief Technology Officer & Co-founder
Global models 5
IIndigo Ag
United States · www.indigoag.com ↗
Discovers and commercializes microbial biologicals (36,000+ strains) for agriculture, the same bioprospecting-to-product model Darwin applies to its Biosolutions line.
$1.4BComparable
GGinkgo Bioworks
United States · www.ginkgobioworks.com ↗
A platform that engineers and scales novel microorganisms into custom products for multiple industries, mirroring Darwin's microbial discovery-to-application pipeline.
$800MComparable
SSolugen
United States · solugen.com ↗
Uses engineered microbial/enzymatic biomanufacturing to replace petrochemical products, matching Darwin's industrial biosolutions focus.
$650MComparable
PPivot Bio
United States · www.pivotbio.com ↗
Develops microbial products (nitrogen-fixing bacteria) for agriculture, directly comparable to Darwin's ag/biocontrol biosolutions work.
$617MComparable
Basecamp Research
United Kingdom · www.basecampresearch.com ↗
Built on global environmental bioprospecting expeditions to discover novel microbial biodiversity, the closest direct analogue to Darwin's core sampling-and-discovery model.
$85MComparable
Investors 5
BBiozell Ventures
CCEEI (Centro Europeo de Empresas e Innovación)
I
Institut Valencià de Competitivitat Empresarial (IVACE)
RRepsol Corporate Venturing
www.repsol.com/en/innovation/corporate-venturing/index.cshtml
SScale the Impact
Funding rounds 1
News & media
No coverage on record yet.